
Aurobindo Pharma Ltd. (AUROPHARM): Aurobindo Pharma Share Price near 52-week high after 0.32% rise
Updated: 29 Sept 2026 • 11:32 am
Posted by:

Aurobindo Pharma Share Price is Rs 1,705.40, up 0.32% on the day, and trading close to its 52-week high with a market capitalisation of Rs 98,464.42 crore. Aurobindo Pharma Share Price Today is drawing attention because the latest quote is still near the yearly high zone, while the stock remains above its recent reference levels. Aurobindo Pharma Stock News is also being tracked for its latest price action, with the move visible in the current market update and without any company-specific catalyst established by the latest Univest data. For readers following Aurobindo Pharma Share Price Live, the immediate focus is the price position, the valuation backdrop and the sector comparison.
Aurobindo Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,705.4 |
| Previous Close | Rs 1,700 |
| Today's Move | +Rs 5.4 (+0.32%) |
| Open | Rs 1,686.65 |
| High | Rs 1,708 |
| Low | Rs 1,686.65 |
| Market Capitalisation | Rs 98,464.42 crore |
Aurobindo Pharma Ltd. (AUROPHARM) traded at Rs 1,705.4 versus the previous close of Rs 1,700, a rise of 0.32%. The stock opened at Rs 1,686.65, reached a high of Rs 1,708 and touched a low of Rs 1,686.65.
Aurobindo Pharma Share Price Today was Rs 1,705.40 versus the previous close of Rs 1,700, a rise of Rs 5.40 or 0.32%. The stock opened at Rs 1,686.65, matched the same level as the day low, and touched Rs 1,708 at the high of the day. Aurobindo Pharma Share Price therefore stayed in a narrow band around the current quote, while the present level also sits close to the 52-week high zone. The distance from the previous close is modest, but the broader setup still places Aurobindo Pharma Share Price near its 52-week peak and keeps Aurobindo Pharma Share News in focus for market participants tracking Aurobindo Pharma Share Price Today. At this point, the latest Univest figures confirm the price event, but they do not establish a company-specific catalyst. That makes the next layer of analysis important for Aurobindo Pharma Share Price.
Aurobindo Pharma Ltd. (AUROPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 98,464.42 crore |
| P/E Ratio | 26.35x |
| P/B Ratio | 2.51x |
| ROE | 9.93% |
| ROCE | 12.76% |
| EPS | Rs 64.52 |
| Book Value Per Share | Rs 676.49 |
| Dividend Yield | 0.24% |
Aurobindo Pharma Ltd. (AUROPHARM) fundamental metrics show P/E 26.35x, P/B 2.51x, ROE 9.93%, ROCE 12.76%. These figures provide context only and are not a buy or sell signal.
Aurobindo Pharma Ltd. has a market capitalisation of Rs 98464.42 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 26.35x, P/B at 2.51x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.93% and ROCE of 12.76%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 64.52, book value per share of Rs 676.49, dividend yield of 0.24%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.3x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 26.35x |
| Benchmark Median P/E | 28.3x |
| Benchmark Average P/E | 41.69x |
| Benchmark P/E Range | 0x to 707.31x |
| Company P/B Ratio | 2.51x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 9.93% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | 12.76% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 98,464.42 crore |
| Benchmark Median Market Cap | Rs 782.41 crore |
Aurobindo Pharma Ltd. (AUROPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Aurobindo Pharma Ltd. (AUROPHARM) has a P/E ratio of 26.35x, which is below the benchmark median of 28.3x, a difference of -6.89%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Aurobindo Pharma Ltd. (AUROPHARM) has a ROE of 9.93%, which is below the benchmark median of 11.74%, a difference of -15.42%. Aurobindo Pharma Ltd. (AUROPHARM) has a ROCE of 12.76%, which is below the benchmark median of 13.63%, a difference of -6.38%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 1,00,395.34 | 31.67 | 2.67 | 11.69 | 13.75 |
| Lupin Ltd. | LUPIN | 95,573.6 | 17.05 | 3.96 | 27.11 | 28.86 |
| Mankind Pharma Ltd. | MANKIND | 1,02,247.25 | 49.33 | 5.99 | 12.69 | 13.24 |
| Laurus Labs Ltd. | LAURUSLABS | 1,08,116.47 | 99.43 | 19.28 | 18.31 | 18.2 |
| Cipla Ltd. | CIPLA | 1,12,875.68 | 33.29 | 3.19 | 11.83 | 16 |
Aurobindo Pharma Ltd. (AUROPHARM) has a P/E ratio of 26.35x compared with the displayed peer median of 33.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.93% compares with a peer median of 12.69% across the companies shown in the table. ROCE stood at 12.76% versus the displayed peer median of 16%, providing a capital-efficiency comparison. Aurobindo Pharma Ltd. (AUROPHARM) has a market capitalisation of Rs 98,464.42 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Aurobindo Pharma
- Aurobindo Pharma Share Price is Rs 1,705.40 and remains near its 52-week high.
- Aurobindo Pharma Share Price Today is up 0.32% versus the previous close.
- Aurobindo Pharma Share Price carries a market cap of Rs 98,464.42 crore.
- Aurobindo Pharma Fundamental Analysis shows a P/E of 26.35 and P/B of 2.51.
- Aurobindo Pharma Share Price is below the peer-group median on ROE and ROCE.
About Aurobindo Pharma
Aurobindo Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Aurobindo Pharma Share Price is linked to a listed company that is tracked on NSE and BSE under the symbol AUROPHARM. The company profile in this article is intentionally limited to the verified sector, industry and financial data used here, so Aurobindo Pharma Share Price News is kept focused on current market metrics, company scale and peer comparison. For readers following Aurobindo Pharma Share Price Today, the main context is the company’s valuation, profitability ratios and position inside a large industry comparison set.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What is Aurobindo Pharma Share Price today?
Ans. Aurobindo Pharma Share Price is Rs 1,705.40. It is up 0.32% from the previous close of Rs 1,700, and the latest quote remains close to the 52-week high zone.
Why is Aurobindo Pharma Share Price in the news?
Ans. Aurobindo Pharma Share Price is in focus because it is trading near its 52-week high. The latest market update shows a small daily rise, but it does not identify a company-specific catalyst.
What was Aurobindo Pharma Share Price Today’s range?
Ans. Aurobindo Pharma Share Price moved between Rs 1,686.65 and Rs 1,708 during the day. The current quote of Rs 1,705.40 sits near the upper end of that range.
How is Aurobindo Pharma Share Price valued?
Ans. Aurobindo Pharma Share Price has a P/E of 26.35 and a P/B of 2.51. Both measures sit below the industry median in the same comparison set, which gives useful valuation context.
What do Aurobindo Pharma EPS and book value show?
Ans. Aurobindo Pharma Share Price is backed by EPS of Rs 64.52 and book value of Rs 676.49. These figures help frame earnings per share and accounting value per share for the stock.
How does Aurobindo Pharma compare with peers?
Ans. Aurobindo Pharma Share Price is close to Dr. Reddy’s Laboratories and Lupin on market cap, while its P/E and P/B are below several peers. ROE and ROCE are also lower than the listed peers here.
What is Aurobindo Pharma Share Price near on a yearly basis?
Ans. Aurobindo Pharma Share Price is near its 52-week high, also called a one-year high or yearly high. The current market quote at Rs 1,705.40 keeps it in that upper price zone.
Should investors track Aurobindo Pharma Share Price on Univest?
Ans. Yes, Aurobindo Pharma Share Price can be tracked on Univest for current price, market cap, valuation ratios and peer context. The platform also helps follow Aurobindo Pharma Stock News and Aurobindo Pharma Share Price Update.
Track Aurobindo Pharma Share Price on Univest
Use Aurobindo Pharma Ltd. (AUROPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Aurobindo Pharma Share Price on Univest for live price updates, 52-week levels, fundamental ratios, market cap context and peer comparison. Aurobindo Pharma Share Price Today can also be checked alongside Aurobindo Pharma Stock News, Aurobindo Pharma Latest News and Aurobindo Pharma Share Price Update in one place.
Recent Articles

Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
13 November 2026

Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
13 November 2026

Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
13 November 2026

Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
13 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
SC Agrotech Bonus Issue and Stock Split: 4:5 Bonus and 1:10 Split Proposed as the Stock Locks a 5% Upper Circuit at Rs 62.38, Q2 Profit Up 48 Times and What Shareholders Should Check Before the 11 December EGM

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





